Rigel Pharmaceuticals (RI2.F) Q2 2026 Earnings

May 5Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
0.08
1
1.92
2.83

Details

Expected EPS
0.67863791614
Actual EPS
0.3754916
Surprise EPS
-0.3
Surprise Percent
-44.67%

Description

⁨Rigel Pharmaceuticals⁩ (⁦RI2.F⁩) has reported earnings of ⁦0.3754916⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts